Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Je nach Börse kann das Aktiensymbol variieren. Zum Beispiel werden Inari Medical-Aktien an der Börse Boerse Stuttgart unter dem Symbol IM7.STU gehandelt.
Wie viele Mitarbeiter hat Inari Medical?▼
Stand September 05, 2026 hat das Unternehmen 800 Mitarbeitende.
In welchem Sektor ist Inari Medical tätig?▼
Inari Medical ist im Sektor Andere tätig.
Wann hat Inari Medical einen Split durchgeführt?▼
Inari Medical hatte in letzter Zeit keine Splits.
Wo hat Inari Medical seinen Hauptsitz?▼
Der Hauptsitz von Inari Medical befindet sich in Irvine, Vereinigte Staaten.